CMMB peer analysis
Chemomab (CMMB) against its competitors: price, today's move, 1-year return and market value side by side.
- CMMB's peers: BIVI (BioVie), CANF (Can-Fite BioPharma), ELAB (PMGC), INM (InMed Pharmaceuticals), KZIA (Kazia Therapeutics), TOVX (Theriva Biologics), XRTX (XORTX Therapeutics).
CMMB and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BIVI BioVie | $0.80 | -12.07% | -41.61% | $8.58M |
| CANF Can-Fite BioPharma | $1.47 | -2.69% | -77.80% | $1.92M |
| ELAB PMGC | $1.17 | -7.87% | -99.90% | $1.37M |
| INM InMed Pharmaceuticals | $15.56 | 17.79% | 812.61% | – |
| KZIA Kazia Therapeutics | $5.05 | -5.96% | -34.75% | $8.18M |
| TOVX Theriva Biologics | $0.13 | -11.11% | -44.42% | $5.87M |
| XRTX XORTX Therapeutics | $0.81 | -8.98% | -70.29% | $1.47M |
| CMMB Chemomab | $1.14 | -26.45% | -57.78% | $9.18M |